Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Miragen Therapeutics Inc (MGEN)

7.25 -0.23 (-3.07%)

05-22 16:00

Open:

7.48

Pre. Close:

7.48

High:

7.51

Low:

7.2

Volume:

80,609

Market Cap:

219M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

7.519 - 7.558

7.558 - 7.592

Low:

7.108 - 7.152

7.152 - 7.189

Close:

7.178 - 7.252

7.252 - 7.316

Technical analysis  (as of: 2018-05-22 4:40:59 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 9.08     One year: 10.60

Support:

Support1: 6.86    Support2: 6.30

Resistance:

Resistance1: 7.77    Resistance2: 9.08

Pivot:

7.48

Moving Averages:

MA(5): 7.43     MA(20): 7.32

MA(100): 7.22     MA(250): 8.82

MACD:

MACD(12,26): 0.16     Signal(12,26,9): 0.18

%K %D:

%K(14,3): 65.75     %D(3): 72.45

RSI:

RSI(14): 50.25

52-Week:

High: 15.91  Low: 5.01  Change(%): -33.5

Average Vol(K):

3-Month: 22512  10-Days 16426

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MGEN has closed above bottom band by 6.7%. Bollinger Bands are 75% narrower than normal. The narrow width of the bands suggests low volatility as compared to MGEN's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-09T22:15:08-04:00
miRagen Therapeutics' (MGEN) CEO William Marshall on Q1 2018 Results - Earnings Call Transcript

2018-05-09T16:18:40-04:00
Miragen Therapeutics beats by $0.08, beats on revenue

2018-05-09T16:18:40-04:00
Miragen Therapeutics beats by $0.08, beats on revenue

2018-05-01T11:17:23-04:00
Second early-stage study of miRagen's MRG-110 on go

2018-03-29T08:52:34-04:00
Premarket analyst action - healthcare

2018-03-28T08:00:00-04:00
Your Daily Pharma Scoop: Esperion Gains On Data, AnaptysBio's ANB020, Tesaro Reports Promising Data

2018-03-27T07:44:11-04:00
Servier launches early-stage study of miRagen's heart failure candidate MRG-110

2018-03-19T08:35:28-04:00
Miragen: Our Take On This RNA Play

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

30.19

Shares Float (M)

29.03

% Held by Insiders

3.90

% Held by Institutions

41.10

Shares Short (K)

741

Shares Short Prior Month (K)

370

Stock Financials

EPS

-1.080

EPS Est. Current Year

-1.520

EPS Est. Next Year

-1.660

EPS Est. Next Quarter

-0.390

Forward EPS

-1.450

Book Value (p.s.)

5.890

PEG Ratio

Profit Margin

Operating Margin

-290.83

Return on Assets (ttm)

-68.7

Return on Equity (ttm)

226.5

Qtrly Rev. Growth

935.5

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.426

Qtrly Earnings Growth

Operating Cash Flow (M)

-27.34

Levered Free Cash Flow (M)

-19.43

atoplab.com

Valuation

P/E

-6.71

P/E Growth Ratio

-0.03

P/BV

1.23

P/S

607993088.00

P/CF

-8.01

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-11-07

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.